Systemic sclerosis biomarkers discovered using mass-spectrometry-based proteomics: a systematic review

  title={Systemic sclerosis biomarkers discovered using mass-spectrometry-based proteomics: a systematic review},
  author={Paul Bălănescu and Anca Lădaru and Eugenia Bălănescu and Cristian Băicuș and Gheorghe Andrei Dan},
  pages={345 - 355}
Abstract Context: Systemic sclerosis (SSc) is an autoimmune disease with incompletely known physiopathology. There is a great challenge to predict its course and therapeutic response using biomarkers. Objective: To critically review proteomic biomarkers discovered from biological specimens from systemic sclerosis patients using mass spectrometry technologies. Methods: Medline and Embase databases were searched in February 2014. Results: Out of the 199 records retrieved, a total of 20 records… Expand
Biomarkers in systemic sclerosis: Their potential to predict clinical courses
The glycoprotein krebs von den Lungen‐6, surfactant protein‐D and CCL18 are promising serum biomarkers of SSc‐related interstitial lung diseases and serum ICAM‐1 levels were predictive for subsequent respiratory dysfunction and serum levels of CXCL8 and P‐selectin were predictive of subsequent physical disability. Expand
Candidate proteomic biomarkers for non-alcoholic fatty liver disease (steatosis and non-alcoholic steatohepatitis) discovered with mass-spectrometry: a systematic review
Critically review proteomic studies that used mass spectrometry techniques and summarize relevant proteomic NAFLD candidate biomarkers to identify some of the biomarkers identified that have already been extensively studied regarding their diagnostic and prognostic capacity. Expand
Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment
This review will summarize studies describing the commonly used and validated biomarkers, the newly emerging and promising SSc biomarkers identified to date, and consideration of future directions in this field. Expand
Comparative analysis of affected and unaffected areas of systemic sclerosis skin biopsies by high-throughput proteomic approaches
Using MS-based proteomics analysis of human skin biopsies from patients with SSc, a number of proteins and pathways that might be involved in SSc progression and pathogenesis are identified and suggest that five may serve as potential biomarkers for SSc. Expand
Genomic and genetic studies of systemic sclerosis: A systematic review.
This review aimed to assess HLA alleles/non-HLA polymorphisms, microsatellites and chromosomal abnormalities that have thus far been associated with SSc and discusses the possible interactions of implicated molecules. Expand
SSc biomarkers detection in the secretome of TGFβ1-activated primary human lung fibroblasts.
The data validate the TGFβ1-induced secretome of NL fibroblasts as a valid in vitro model that reflects SSc biomarkers and identify potential therapeutic targets for SSc-PF. Expand
S100A6, Calumenin and Cytohesin 2 as Biomarkers for Cutaneous Involvement in Systemic Sclerosis Patients: A Case Control Study
Calumenin had the best predictive capacity for cutaneous Ssc manifestations and was confirmed as biomarkers on an independent group of Ssc patients. Expand
Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study
Endocan is expressed by endothelial cells and associated with endothelial dysfunction; therefore it could be a potential biomarker for Ssc patients. Expand
Investigation Of Small Molecular Substances As Potential Biomarkers For Discrimination Of Gastric Tumor
Results suggest that further investigations of the functions of 5-aminoimidazole and serylproline might provide a better understanding of the underlying mechanisms involved in GT. Expand
OTT_A_221589 8587..8594
1Department of General Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province 550004, People’s Republic of China; 2Department of Thoracic Surgery, The SecondExpand


Proteomic analysis of Systemic Sclerosis serum identifies the toll-like receptor agonists S100A8/A9 as a novel possible pathogenic marker
This study is the first study that exploits a proteome-wide profiling to identify new targets in the pathogenesis of SSc, an autoimmune disease characterized by fibrosis of the skin and the internal organs. Expand
Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes
It is demonstrated that salivary fluid might represent a novel ideal milieu for the detection of a diagnostic panel of candidate biomarkers for pSS, and to gain an insight into the pathogenetic processes underlying glandular and systemic autoimmune disorders. Expand
Using Proteomic Analysis for Studying the Skin Fibroblast Protein Profile in Systemic Sclerosis
Proteomics is defined as the large-scale study of proteins expressed for a specific tissue from a genome, (global proteomics) or differentially expressed proteins (differential proteomics). Expand
Towards a functional proteomics approach to the comprehension of idiopathic pulmonary fibrosis, sarcoidosis, systemic sclerosis and pulmonary Langerhans cell histiocytosis.
This is the first study where different interstitial lung diseases such as sarcoidosis, idiopathic pulmonary fibrosis, pulmonary Langerhans cell histiocytosis, fibrosis associated to systemic sclerosis and smoker and non smoker control subjects were compared in a proteomic study to highlight their common pathways. Expand
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
It is asserted that successful studies generally use suitable statistical approaches for biomarker definition and confirm results in independent test sets and a brief set of practical and feasible recommendations are described for investigators to properly identify and qualify proteomic biomarkers, which could also be used as reporting requirements. Expand
Comparative Proteomic Analysis of Serum from Patients with Systemic Sclerosis and Sclerodermatous GVHD. Evidence of Defective Function of Factor H
The comparative proteomic analysis of serum from SSc and ScGVHD patients highlighted proteins involved in either promoting or maintaining an inflammatory state and found a defective function of Factor H, possibly associated with ECs damage. Expand
Upregulated and downregulated proteins in hepatocellular carcinoma: a systematic review of proteomic profiling studies.
Five candidate proteins were defined as potential biomarkers for HCC, which may have diagnostic, prognostic and therapeutic significance, and were identified by validating data on differentially expressed proteins reported by studies on HCC tissues. Expand
Proteome analysis of bronchoalveolar lavage fluid in lung fibrosis associated with systemic sclerosis.
Several interesting proteins that might have roles in ILD of SSc patients are identified and further studies are warranted to clarify the role of these proteins in the processes of pulmonary fibrosis in SSc. Expand
Serum Proteome of Patients with Systemic Sclerosis: Molecular Analysis of Expression and Prevalence of Haptoglobin Alpha Chain Isoforms
The results demonstrate that c spots are more prevalent in SSc patients than in controls, and the c and e spots can be considered markers for SSc and thus be of use for the early diagnosis of connective tissue disorders and in establishing appropriate treatment. Expand
Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis.
This study is the first reporting the WS protein pattern of patients with SSc and comparing the differences between WS of patientsWith systemic sclerosis and WS of healthy subjects, both previously identified and newly identified proteins were detected in WS using a proteomic approach. Expand